Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Malcolm Fraser

Geriatric Medicine Brooksville, FL Medical Doctor

NPI 1861486177 CMS profile 444952

605 Lamar Ave, Brooksville, FL 34601

Open in the dashboard

General payments

$358,713

648 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Malcolm Fraser of Brooksville, FL is reported in the CMS Open Payments database as having received $358,713 across 648 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Geriatric Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $49,298 96
2024 General $63,873 108
2023 General $73,282 134
2022 General $47,408 93
2021 General $25,867 49
2020 General $16,544 22
2019 General $82,440 146

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Malcolm Fraser
  • Geriatric Medicine median
  • Middle half of Geriatric Medicine
  • National median

In program year 2025, general payments to Malcolm Fraser were reported at $49,298. Among 512 Geriatric Medicine profiles paid that year, the median was $120 and the middle half received between $37 and $350.

Show as a table
Year Malcolm Fraser Geriatric Medicine median Middle half National median
2019 $82,440 $96 $28–$339 $163
2020 $16,544 $99 $28–$262 $114
2021 $25,867 $94 $27–$318 $132
2022 $47,408 $103 $34–$338 $149
2023 $73,282 $109 $39–$320 $160
2024 $63,873 $125 $36–$371 $164
2025 $49,298 $120 $37–$350 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. ACADIA Pharmaceuticals Inc $163,422 330 payments
  2. Neurocrine Biosciences, Inc. $106,529 166 payments
  3. Lilly USA, LLC $20,770 31 payments
  4. Sunovion Pharmaceuticals Inc. $19,256 48 payments
  5. Janssen Pharmaceuticals, Inc $15,259 24 payments
  6. Allergan Inc. $10,408 16 payments
  7. Sumitomo Pharma America, Inc. $6,474 11 payments
  8. Urovant Sciences Inc $6,264 10 payments
  9. Avanir Pharmaceuticals, Inc. $4,361 4 payments
  10. Sun Pharmaceutical Industries Inc. $3,404 2 payments
  11. Other $2,565 6 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $221,947 116 payments
  2. Travel and Lodging $61,549 288 payments
  3. Consulting Fee $59,760 32 payments
  4. Food and Beverage $12,066 209 payments
  5. Honoraria $3,376 1 payment
  6. Education $17 2 payments
Products named General payments · program years 2019–2025
  1. NUPLAZID Parkinsons Disease Psychosis $107,674 237 payments
  2. INGREZZA $106,529 166 payments
  3. NUPLAZID Parkinsons Disease Psychosis $43,733 65 payments
  4. LONHALA MAGNAIR $19,244 47 payments
  5. TRULICITY $18,971 29 payments
  6. XARELTO $15,259 24 payments
  7. GEMTESA $12,739 21 payments
  8. NUPLAZID Pdp $12,016 28 payments
  9. NAMZARIC $10,385 15 payments
  10. DRIZALMA SPRINKLE $3,376 1 payment
  11. Other $2,865 14 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

648 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Geriatric Medicine in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record